A new recombinant MS-superoxide dismutase alleviates 5-fluorouracil-induced intestinal mucositis in mice

Intestinal mucositis is a common side effect of anticancer regimens that exerts a negative impact on chemotherapy. Superoxide dismutase (SOD) is a potential therapy for mucositis but efficient product is not available because the enzyme is degraded following oral administration or induces an immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Xiao-xia, Li, Hai-long, Zhang, Yi-ting, Wu, Shou-yan, Lu, Heng-lei, Yu, Xiao-lu, Meng, Fan-guo, Sun, Jian-hua, Gong, Li-kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468365/
https://www.ncbi.nlm.nih.gov/pubmed/31506573
http://dx.doi.org/10.1038/s41401-019-0295-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468365/
https://www.ncbi.nlm.nih.gov/pubmed/31506573
http://dx.doi.org/10.1038/s41401-019-0295-8

Ejemplares similares